Moneycontrol

You are Here : See 20% EBITDA growth in FY14: Alembic Pharma

Wednesday, 03:50

In an interview to CNBC-TV18, Amin adds that the company, despite the drug pricing policy, will grow at 15 percent.
MAY 30, 2017
04:54 PM

cnbc tv18 shows

Search
All Shows
Go

NOW PLAYING

Markets Today

What's happened in the markets through the day? What are top experts & brokerages betting on? What's happening in the global economy? What about market moving business stories? Which government policies will impact the markets? For all this & more, watch Markets Today - a show that g ... more »

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Sections
Follow us on
Available On